Industry Considerations with Phase III Clinical Trials II

Loading...
Do curso por University of California San Diego
Drug Development
212 classificações
University of California San Diego
212 classificações
Na lição
Industry Considerations with Phase III Clinical Trials, Katie Lyons, Pharm.D. and Kelly Hogan, Pharm. D.

Conheça os instrutores

  • Williams S. Ettouati, Pharm.D.
    Williams S. Ettouati, Pharm.D.
    Director, Industrial Relations & Development; Health Sciences Associate Clinical Professor, N.S.
    Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Joseph D. Ma
    Joseph D. Ma
    Associate Professor of Clinical Pharmacy
    Skaggs School of Pharmacy and Pharmaceutical Sciences

Explore nosso catálogo

Registre-se gratuitamente e obtenha recomendações, atualizações e ofertas personalizadas.